Efficacy and tolerability of febuxostat in gout patients on dialysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and tolerability of febuxostat in gout patients on dialysis

Published:2021-03 Issue:3 Volume:51 Page:348-354
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Choi See Y.¹,Choi Seung W.¹,Lee Sunggun²,So Min W.³,Oh Ji S.⁴,Lim Doo‐Ho¹^ORCID

Affiliation:

1. Division of Rheumatology, Department of Internal Medicine University of Ulsan College of Medicine, Ulsan University Hospital Ulsan South Korea

2. Division of Rheumatology, Department of Internal Medicine Haeundae Paik Hospital, Inje University College of Medicine Busan South Korea

3. Division of Rheumatology, Department of Internal Medicine Pusan National University Yangsan Hospital Yangsan South Korea

4. Department of Biomedical Informatics, Asan Medical Center University of Ulsan College of Medicine Seoul South Korea

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.14776

Reference33 articles.

1. Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout;Gaffo AL;Core Evid,2009

2. A new xanthine oxidase inhibitor: the uric acid reduction and additional efficacy in CKD patients

3. Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout

4. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)

5. Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of gout treatments in people with renal impairment;Exploration of Musculoskeletal Diseases;2024-09-02

2. Urate lowering therapy in patients starting hemodialysis limit gout flares occurrence: ten years retrospective study;BMC Nephrology;2024-08-20

3. Febuxostat dose requirement according to renal function in patients who achieve target serum urate levels: A retrospective cohort study;Joint Bone Spine;2024-03

4. Epidemiology and treatment-related concerns of gout and hyperuricemia in Korean;Journal of Rheumatic Diseases;2023-04-01

5. Comparison between the Effects of Allopurinol and Febuxostat on the Survival of Patients on Maintenance Hemodialysis;American Journal of Nephrology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3